🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sophie Alain

Inserm

ORCID: 0000-0002-9787-1421

Also affiliated with Université de Limoges

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.

78 citations

Sophie Alain, Carlos Cervera, Roy F. Chemaly, Camille N. Kotton, Jens Lundgren +7 more

44 citations

Hamed Rabiei, Perrine Coste-Mazeau, Sebastien Hantz, Sophie Alain, Jean-Luc Eyraud +7 more